Correction to: How Does the Public Evaluate Vaccines for Low‑Incidence, Severe‑Outcome Diseases? A General‑Population Choice Experiment

Reed Johnson, F.; Fairchild, Angelyn; Whittington, Dale; Srivastava, Amit K.; Gonzalez, Juan Marcos; Huang, Liping

doi:10.1007/s40271-023-00620-3

Correction to: How Does the Public Evaluate Vaccines for Low‑Incidence, Severe‑Outcome Diseases? A General‑Population Choice Experiment

Correction
Published: 13 March 2023

Volume 16, page 287, (2023)
Cite this article

Download PDF

The Patient - Patient-Centered Outcomes Research Aims and scope Submit manuscript

Correction to: How Does the Public Evaluate Vaccines for Low‑Incidence, Severe‑Outcome Diseases? A General‑Population Choice Experiment

Download PDF

F. Reed Johnson ORCID: orcid.org/0000-0002-7572-2150¹,
Angelyn Fairchild²,
Dale Whittington^3,4,
Amit K. Srivastava^5,8,
Juan Marcos Gonzalez⁶ &
…
Liping Huang⁷

880 Accesses
8 Altmetric
1 Mention
Explore all metrics

The Original Article was published on 13 December 2022

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: The Patient - Patient-Centered Outcomes Research (2023) 16:139–151 https://doi.org/10.1007/s40271-022-00602-x

In this article the author name Liping Huang was incorrectly written as Liping Huan.

The original article has been corrected.

Author information

Authors and Affiliations

Duke Clinical Research Institute, Duke University, 300 West Morgan Street, Durham, NC, 27701, USA
F. Reed Johnson
Angelyn Fairchild Kenan-Flagler School of Business, University of North Carolina, Chapel Hill, NC, USA
Angelyn Fairchild
Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA
Dale Whittington
Global Development Institute, University of Manchester, Manchester, UK
Dale Whittington
Medical Development and Scientifc Clinical Afairs, Pfzer Vaccines, Collegeville, PA, USA
Amit K. Srivastava
Duke Clinical Research Institute, Duke University, Durham, NC, USA
Juan Marcos Gonzalez
Health Economics and Outcomes Research, Pfzer Inc., Collegeville, PA, USA
Liping Huang
Orbital Therapeutics, Cambridge, MA, USA
Amit K. Srivastava

Authors

F. Reed Johnson
View author publications
You can also search for this author in PubMed Google Scholar
Angelyn Fairchild
View author publications
You can also search for this author in PubMed Google Scholar
Dale Whittington
View author publications
You can also search for this author in PubMed Google Scholar
Amit K. Srivastava
View author publications
You can also search for this author in PubMed Google Scholar
Juan Marcos Gonzalez
View author publications
You can also search for this author in PubMed Google Scholar
Liping Huang
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Reed Johnson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reed Johnson, F., Fairchild, A., Whittington, D. et al. Correction to: How Does the Public Evaluate Vaccines for Low‑Incidence, Severe‑Outcome Diseases? A General‑Population Choice Experiment. Patient 16, 287 (2023). https://doi.org/10.1007/s40271-023-00620-3

Download citation

Published: 13 March 2023
Issue Date: May 2023
DOI: https://doi.org/10.1007/s40271-023-00620-3

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: How Does the Public Evaluate Vaccines for Low‑Incidence, Severe‑Outcome Diseases? A General‑Population Choice Experiment

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation